Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use.

[1]  S. Grieve,et al.  Prevalence, distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus: a cardiac magnetic resonance study , 2016, Lupus.

[2]  L. Anderson,et al.  The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure. , 2016, Cardiac failure review.

[3]  G. Kitas,et al.  Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms , 2015, Annals of the rheumatic diseases.

[4]  Masami Takei,et al.  Detection of left ventricular regional dysfunction and myocardial abnormalities using complementary cardiac magnetic resonance imaging in patients with systemic sclerosis without cardiac symptoms , 2014, Journal of Cardiovascular Magnetic Resonance.

[5]  G. Kitas,et al.  Cardiovascular comorbidity in rheumatic diseases , 2015, Nature Reviews Rheumatology.

[6]  J. Block,et al.  Premature Mortality: A Neglected Outcome in Rheumatic Diseases? , 2015, Arthritis care & research.

[7]  C. Bombardier,et al.  Trends in Excess Mortality Among Patients With Rheumatoid Arthritis in Ontario, Canada , 2015, Arthritis care & research.

[8]  P. Matthews,et al.  Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping. , 2015, JACC. Cardiovascular imaging.

[9]  C. Nuñez-Alvarez,et al.  Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography. , 2015, Rheumatology.

[10]  Y. Pinto,et al.  Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations. , 2015, Cardiovascular research.

[11]  J. Reiber,et al.  Cardiovascular Magnetic Resonance Imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis. , 2015, Inflammation & allergy drug targets.

[12]  G. Kitas,et al.  Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis , 2014, Annals of the rheumatic diseases.

[13]  M. Cerinic,et al.  Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance. , 2015, European heart journal cardiovascular Imaging.

[14]  Stefan L. Zimmerman,et al.  Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus , 2015, The International Journal of Cardiovascular Imaging.

[15]  M. Takei,et al.  Tocilizumab Treatment Increases Left Ventricular Ejection Fraction and Decreases Left Ventricular Mass Index in Patients with Rheumatoid Arthritis without Cardiac Symptoms: Assessed Using 3.0 Tesla Cardiac Magnetic Resonance Imaging , 2014, The Journal of Rheumatology.

[16]  G. Kitas,et al.  Heart failure imaging patterns in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance. , 2014, International journal of cardiology.

[17]  Leon Axel,et al.  Evaluation of diastolic function by three-dimensional volume tracking of the mitral annulus with cardiovascular magnetic resonance: comparison with tissue Doppler imaging , 2014, Journal of Cardiovascular Magnetic Resonance.

[18]  M. Lunt,et al.  Mortality Trends in Patients With Early Rheumatoid Arthritis Over 20 Years: Results From the Norfolk Arthritis Register , 2014, Arthritis care & research.

[19]  M. Robson,et al.  Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents , 2014, Journal of Cardiovascular Magnetic Resonance.

[20]  G. Kitas,et al.  Rheumatoid arthritis: an autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: role of cardiovascular magnetic resonance. , 2014, Inflammation & allergy drug targets.

[21]  S. Mackie,et al.  Vasculitis syndromes: Dealing with increased vascular risk and mortality in GCA , 2014, Nature Reviews Rheumatology.

[22]  S. Gabriel,et al.  Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure. , 2014, Heart failure clinics.

[23]  J. Reiber,et al.  Myocardial stress perfusion-fibrosis imaging pattern in sarcoidosis, assessed by cardiovascular magnetic resonance imaging. , 2014, International Journal of Cardiology.

[24]  Jane Nixon,et al.  Comparison of Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography in Women With Suspected Coronary Artery Disease From the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial , 2014, Circulation.

[25]  P. Matthews,et al.  Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis – a clinical study using myocardial T1-mapping and extracellular volume quantification , 2014, Journal of Cardiovascular Magnetic Resonance.

[26]  G. Kitas,et al.  Micro- and macrovascular treatment targets in scleroderma heart disease. , 2014, Current pharmaceutical design.

[27]  P. Croisille,et al.  Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis. , 2014, Radiology.

[28]  Sophie Mavrogeni,et al.  Cardiac Tissue Characterization and the Diagnostic Value of Cardiovascular Magnetic Resonance in Systemic Connective Tissue Diseases , 2014, Arthritis care & research.

[29]  S Maderwald,et al.  Cardiac MRI: T2-Mapping Versus T2-Weighted Dark-Blood TSE Imaging for Myocardial Edema Visualization in Acute Myocardial Infarction , 2013, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[30]  M. Budoff,et al.  Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease , 2013, Annals of the rheumatic diseases.

[31]  T. Nakata,et al.  The Spectrum of Findings in Supra-Aortic Takayasu’s Arteritis as Seen on Spiral CT Angiography and Digital Subtraction Angiography , 2001, CardioVascular and Interventional Radiology.

[32]  S. Radovanović,et al.  Does the presence of secondary antiphospholipid syndrome in patients with systemic lupus erythematodes accelerate carotid arteries intima-media thickness changes? , 2014, Rheumatology International.

[33]  Daniel S Berman,et al.  Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls. , 2013, Cardiovascular diagnosis and therapy.

[34]  G. Kitas,et al.  Heart involvement in rheumatoid arthritis: multimodality imaging and the emerging role of cardiac magnetic resonance. , 2013, Seminars in arthritis and rheumatism.

[35]  G. Kolovou,et al.  Imaging patterns of heart failure in rheumatoid arthritis evaluated by cardiovascular magnetic resonance. , 2013, International journal of cardiology.

[36]  G. Kitas,et al.  Diffuse, subendocardial vasculitis. A new entity identified by cardiovascular magnetic resonance and its clinical implications. , 2013, International journal of cardiology.

[37]  Stefan Neubauer,et al.  T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. , 2013, JACC. Cardiovascular imaging.

[38]  J. Taylor.  New ESC guidelines published on stable coronary artery disease. , 2013, European heart journal.

[39]  S. Gabriel,et al.  Rheumatoid arthritis and cardiovascular disease. , 2013, American heart journal.

[40]  G. Kolovou,et al.  Cardiac involvement in ANCA (+) and ANCA (-) Churg-Strauss syndrome evaluated by cardiovascular magnetic resonance. , 2013, Inflammation & allergy drug targets.

[41]  G. Kolovou,et al.  The Greek cardiac magnetic resonance experience: a comparison with the EuroCMR Registry. , 2013, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[42]  René M. Botnar,et al.  The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease , 2013, The International Journal of Cardiovascular Imaging.

[43]  M. Wasko,et al.  Cardiovascular disease in autoimmune rheumatic diseases. , 2013, Autoimmunity reviews.

[44]  K. Costenbader,et al.  The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. , 2013, Seminars in arthritis and rheumatism.

[45]  G. Kolovou,et al.  Myopericarditis, as the first sign of rheumatoid arthritis relapse, evaluated by cardiac magnetic resonance. , 2013, Inflammation & allergy drug targets.

[46]  A. Nasis,et al.  Current and evolving clinical applications of multidetector cardiac CT in assessment of structural heart disease. , 2013, Radiology.

[47]  M. Robson,et al.  Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.

[48]  U. Kramer,et al.  CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. , 2013, JACC. Cardiovascular imaging.

[49]  S. Mavrogeni,et al.  Systemic vasculitis: an underestimated cause of heart failure - assessment by cardiovascular magnetic resonance. , 2013, Reviews in cardiovascular medicine.

[50]  G. Kolovou,et al.  Myocarditis during acute inflammatory myopathies: evaluation using clinical criteria and cardiac magnetic resonance imaging. , 2013, International Journal of Cardiology.

[51]  L. Cooper,et al.  We see only what we look for: imaging cardiac inflammation. , 2013, Circulation. Cardiovascular imaging.

[52]  E. Nagel,et al.  Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.

[53]  S. Mavrogeni,et al.  Pleuro-pericarditis, vasculitis, subendocardial and nodular biventricular fibrosis. The multiple faces of systemic sclerosis detected by cardiac magnetic resonance in the same patient. , 2013, International journal of cardiology.

[54]  J. Tervaert.  Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides. , 2013 .

[55]  G. Kitas,et al.  The role of multimodality imaging in the evaluation of Takayasu arteritis. , 2013, Seminars in arthritis and rheumatism.

[56]  E. Nagel,et al.  European cardiovascular magnetic resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries , 2013, Journal of Cardiovascular Magnetic Resonance.

[57]  G. Kolovou,et al.  The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis , 2013, Lupus.

[58]  B. Carter.  2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology , 2013 .

[59]  W. Szczeklik,et al.  Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg–Strauss syndrome and granulomatosis with polyangiitis (Wegener’s) in patients with normal electrocardiograms and transthoracic echocardiography , 2012, The International Journal of Cardiovascular Imaging.

[60]  G. Kitas,et al.  Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis. , 2012, Autoimmunity reviews.

[61]  S. Raman,et al.  CMR in inflammatory vasculitis , 2012, Journal of Cardiovascular Magnetic Resonance.

[62]  G. Kitas,et al.  The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study , 2012, Arthritis Research & Therapy.

[63]  J. Reiber,et al.  Myocardial perfusion-fibrosis pattern in systemic sclerosis assessed by cardiac magnetic resonance. , 2012, International journal of cardiology.

[64]  Xiangying Du,et al.  3.0T Whole-Heart Coronary Magnetic Resonance Angiography Performed With 32-Channel Cardiac Coils: A Single-Center Experience , 2012, Circulation. Cardiovascular imaging.

[65]  F. Ingegnoli,et al.  Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis. , 2012, Current vascular pharmacology.

[66]  Igor Klem,et al.  Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation , 2011, Journal of the American College of Cardiology.

[67]  A. Angelini,et al.  2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. , 2012, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[68]  Jim M Wild,et al.  Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry , 2012, Journal of Cardiovascular Magnetic Resonance.

[69]  M. Robson,et al.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[70]  Y. Allanore,et al.  Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. , 2012, Rheumatology.

[71]  E. Nagel,et al.  Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis. , 2012, Journal of the American College of Cardiology.

[72]  Damini Dey,et al.  State-of-the-art in CT hardware and scan modes for cardiovascular CT. , 2012, Journal of cardiovascular computed tomography.

[73]  K. Klingel,et al.  Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. , 2012, Journal of the American College of Cardiology.

[74]  Z. Fayad,et al.  Noninvasive cardiovascular imaging in rheumatoid arthritis: current modalities and the emerging role of magnetic resonance and positron emission tomography imaging. , 2012, Seminars in arthritis and rheumatism.

[75]  A. Gasparyan.  Editorial [Hot Topic: Cardiovascular Risk and Inflammation: Pathophysiological Mechanisms, Drug Design, and Targets Executive (Guest Editor: Armen Yuri Gasparyan)] , 2012 .

[76]  G. Kitas,et al.  Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets. , 2012, Current pharmaceutical design.

[77]  S. Abdulaziz,et al.  CARDIOVASCULAR INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS , 2012, European Heart Journal Supplements.

[78]  G. Kolovou,et al.  Pathophysiology of Q waves in II, III, avF in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance imaging , 2012, Lupus.

[79]  Sophie Mavrogeni,et al.  Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis , 2012, Nature Reviews Rheumatology.

[80]  M. Robson,et al.  Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction , 2012, Journal of Cardiovascular Magnetic Resonance.

[81]  S. Plein,et al.  Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial , 2012, The Lancet.

[82]  A. Mathieu,et al.  The growing role of cardiac magnetic resonance imaging in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis. , 2012, Seminars in arthritis and rheumatism.

[83]  J. Spertus,et al.  ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Am , 2012, Journal of the American College of Cardiology.

[84]  M. Szklo,et al.  Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. , 2012, Seminars in arthritis and rheumatism.

[85]  B. Bresnihan,et al.  Pulmonary Fibrosis in Systemic Sclerosis: Association With Myocardial Fibrosis , 2012, Journal of thoracic imaging.

[86]  小林 泰之.  Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach : a pilot study , 2012 .

[87]  A. Gasparyan.  Cardiovascular risk and inflammation: pathophysiological mechanisms, drug design, and targets. , 2012, Current pharmaceutical design.

[88]  F. Torres.  Cardiac MR imaging for the evaluation of autoimmune myocarditis , 2012, Rheumatology International.

[89]  J. S. Muhammad,et al.  Pulmonary Hypertension in Systemic Sclerosis , 2011 .

[90]  N. Maredia,et al.  3D Echo systematically underestimates right ventricular volumes compared to cardiovascular magnetic resonance in adult congenital heart disease patients with moderate or severe RV dilatation , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[91]  S. Mavrogeni,et al.  Is there a place for cardiovascular magnetic resonance imaging in the evaluation of cardiovascular involvement in rheumatic diseases? , 2011, Seminars in arthritis and rheumatism.

[92]  S. Mavrogeni,et al.  Contrast-enhanced CMR imaging reveals myocardial involvement in idiopathic inflammatory myopathy without cardiac manifestations. , 2011, JACC. Cardiovascular imaging.

[93]  Amit R. Patel,et al.  Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study , 2011, European journal of heart failure.

[94]  A. Levy,et al.  Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. , 2011, Arthritis and rheumatism.

[95]  D. Carroll,et al.  Vascular function and morphology in rheumatoid arthritis: a systematic review. , 2011, Rheumatology.

[96]  G. Kolovou,et al.  Systemic lupus erythematosus: Two sides of the same coin evaluated by cardiovascular magnetic resonance imaging , 2011, Lupus.

[97]  G. Kolovou,et al.  Cardiac magnetic resonance for early detection and risk stratification of patients with non‐compaction cardiomyopathy , 2011, European journal of heart failure.

[98]  G. Kolovou,et al.  CMR evaluation of cardiac involvement during the convalescence of Kawasaki disease. , 2011, JACC. Cardiovascular imaging.

[99]  P. Poole‐Wilson,et al.  Role of Cardiovascular Magnetic Resonance as a Gatekeeper to Invasive Coronary Angiography in Patients Presenting With Heart Failure of Unknown Etiology , 2011, Circulation.

[100]  G. Kolovou,et al.  Myocarditis as a precipitating factor for heart failure: evaluation and 1‐year follow‐up using cardiovascular magnetic resonance and endomyocardial biopsy , 2011, European journal of heart failure.

[101]  Zhonghua Sun,et al.  Multislice computed tomography angiography in the diagnosis of coronary artery disease , 2011, Journal of geriatric cardiology : JGC.

[102]  S. Gabriel,et al.  Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE , 2011, Nature Reviews Rheumatology.

[103]  R. Schwartz,et al.  Accuracy and safety of high pitch computed tomography imaging in young children with complex congenital heart disease. , 2011, The American journal of cardiology.

[104]  G. Plant,et al.  Cardiovascular magnetic resonance in cardiac sarcoidosis with MR conditional pacemaker in situ , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[105]  S. Mavrogeni,et al.  Coronary artery abnormalities in CREST syndrome revealed by cardiovascular magnetic resonance imaging. , 2011, The Canadian journal of cardiology.

[106]  Stefan Neubauer,et al.  Dynamic Changes of Edema and Late Gadolinium Enhancement After Acute Myocardial Infarction and Their Relationship to Functional Recovery and Salvage Index , 2011, Circulation. Cardiovascular imaging.

[107]  S. Mavrogeni,et al.  Myocarditis and subclavian stenosis in Takayasu arteritis. , 2011, International journal of cardiology.

[108]  G. Kitas,et al.  Cardiovascular risk in rheumatoid arthritis and diabetes: how does it compare and when does it start? , 2011, Annals of the rheumatic diseases.

[109]  M. Ugander,et al.  Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease , 2011, Scandinavian journal of rheumatology.

[110]  Warren J Manning,et al.  ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[111]  A. Shamsul,et al.  A cross‐sectional study of diastolic dysfunction in rheumatoid arthritis and its association with disease activity , 2011, International journal of rheumatic diseases.

[112]  S. Gabriel,et al.  Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives , 2010, Annals of the rheumatic diseases.

[113]  D. Berman,et al.  Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. , 2011, JACC. Cardiovascular imaging.

[114]  H. Ackermann,et al.  myocarditis: comparison of MR and histological , 2022 .

[115]  M. Hayward,et al.  Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.

[116]  G. Giannakoulas,et al.  Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis , 2010, Clinical Rheumatology.

[117]  G. Giannakoulas,et al.  Early Detection of Cardiac Involvement in Systemic Sclerosis Assessed by Tissue-Doppler Echocardiography: Relationship with Neurohormonal Activation and Endothelial Dysfunction , 2010, Journal of Rheumatology.

[118]  M. Szklo,et al.  Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. , 2010, Arthritis and rheumatism.

[119]  R. Pecoits-Filho,et al.  Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis , 2010, Rheumatology International.

[120]  J. Pope,et al.  Determinants of morbidity and mortality of systemic sclerosis in Canada. , 2010, Seminars in arthritis and rheumatism.

[121]  H. Katus,et al.  Myocardial Left Ventricular Dysfunction in Patients with Systemic Lupus Erythematosus: New Insights from Tissue Doppler and Strain Imaging , 2010, The Journal of Rheumatology.

[122]  B. Schnackenburg,et al.  Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study , 2009, Rheumatology.

[123]  S. Adelstein,et al.  Use of cardiac MR imaging to evaluate the presence of myocarditis in autoimmune myositis: three cases , 2012, Rheumatology International.

[124]  K. Klingel,et al.  Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. , 2009, European heart journal.

[125]  G. Kolovou,et al.  Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy. , 2009, Inflammation & allergy drug targets.

[126]  R. Kim,et al.  Detection of Myocardial Damage in Patients With Sarcoidosis , 2009, Circulation.

[127]  D. Pennell,et al.  Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance. , 2009, Arthritis and rheumatism.

[128]  J. Francis,et al.  The role of cardiovascular magnetic resonance imaging in heart failure. , 2009, Journal of the American College of Cardiology.

[129]  J. Wild,et al.  Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension. , 2009, Rheumatology.

[130]  S. Mavrogeni,et al.  "Cardiovascular magnetic resonance imaging reveals myocardial inflammation and coronary artery ectasia during the acute phase of Kawasaki disease". , 2009, International journal of cardiology.

[131]  D. Panagiotakos,et al.  Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. , 2009, Arthritis and rheumatism.

[132]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[133]  Tao-Cheng Wu,et al.  Focal myocarditis mimicking myocardial infarction in a patient with rheumatoid arthritis , 2009, Clinical Rheumatology.

[134]  S. Mavrogeni,et al.  Detection of myocardial inflammation by contrast-enhanced MRI in a patient with Churg-Strauss syndrome. , 2009, International journal of cardiology.

[135]  K. Fontaine,et al.  Cardiac Magnetic Resonance Imaging with Pharmacological Stress Perfusion and Delayed Enhancement in Asymptomatic Patients with Systemic Sclerosis , 2008, The Journal of Rheumatology.

[136]  N. Lamblin,et al.  Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients , 2008, Annals of the rheumatic diseases.

[137]  Jens-Uwe Voigt,et al.  Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). , 2008, European heart journal.

[138]  A. Giunta,et al.  Regional diastolic function by tissue Doppler echocardiography in systemic sclerosis: correlation with clinical variables , 2009, Rheumatology International.

[139]  Mohsen Sadatsafavi,et al.  Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. , 2008, Arthritis and rheumatism.

[140]  J. Barkhausen,et al.  Detection of Myocardial Fibrosis in Systemic Sclerosis by Contrast-Enhanced Magnetic Resonance Imaging , 2008, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[141]  P. Libby.  Role of inflammation in atherosclerosis associated with rheumatoid arthritis. , 2008, The American journal of medicine.

[142]  S. Heymans,et al.  Acute viral myocarditis , 2008, European heart journal.

[143]  Jose Luis Zamorano,et al.  Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[144]  D. Pennell,et al.  The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. , 2008, European heart journal.

[145]  Yun Yuan,et al.  Encephalic large arteries narrowness and peripheral neuropathy in a patient with adult-onset Still’s disease , 2008, Rheumatology International.

[146]  J. Glockner,et al.  MR imaging of the pericardium. , 2008, Magnetic resonance imaging clinics of North America.

[147]  O. Vignaux,et al.  Rituximab reversed cardiac involvement of Wegener's granulomatosis: magnetic resonance imaging assessment. , 2008, Presse medicale.

[148]  A. van Rossum,et al.  MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. , 2008, European heart journal.

[149]  D. Pennell,et al.  Cardiovascular magnetic resonance made easy , 2008 .

[150]  M. Wisłowska,et al.  Diastolic heart function in RA patients , 2008, Rheumatology International.

[151]  Frank J Rybicki,et al.  Biochemical safety profiles of gadolinium‐based extracellular contrast agents and nephrogenic systemic fibrosis , 2007, Journal of magnetic resonance imaging : JMRI.

[152]  T. Therneau,et al.  The widening mortality gap between rheumatoid arthritis patients and the general population. , 2007, Arthritis and rheumatism.

[153]  H. Kauczor,et al.  Visualization of coronary arteries in patients after childhood Kawasaki syndrome: value of multidetector CT and MR imaging in comparison to conventional coronary catheterization , 2007, Pediatric Radiology.

[154]  L. Guillevin,et al.  Imagerie cardiaque dans les vascularites associées aux ANCA , 2007 .

[155]  S. Gabriel,et al.  Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. , 2007, The Journal of rheumatology.

[156]  E. McVeigh,et al.  T2‐prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo , 2007, Magnetic resonance in medicine.

[157]  T. Gheita,et al.  Hughes–Stovin syndrome: is it incomplete Behçet’s? , 2007, Clinical Rheumatology.

[158]  Z. Kornacewicz-Jach,et al.  Heart Failure in Systemic Lupus Erythematosus Treated by Cardiac Resynchronization , 2007, Angiology.

[159]  N. Bornstein,et al.  Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. , 2007, Seminars in arthritis and rheumatism.

[160]  T. Medsger,et al.  1972-2002in causes of death in systemic sclerosis, , 2007 .

[161]  O. Vignaux,et al.  [Cardiac imaging in ANCA-associated vasculitis]. , 2007, Presse medicale.

[162]  Kan Takeda,et al.  Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. , 2006, Journal of the American College of Cardiology.

[163]  Manesh R. Patel,et al.  ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group. , 2006, Journal of the American College of Radiology : JACR.

[164]  J. Avorn,et al.  Patterns of cardiovascular risk in rheumatoid arthritis , 2006, Annals of the rheumatic diseases.

[165]  Roger B. Davis,et al.  Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.

[166]  S. Abou-Raya,et al.  Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. , 2006, Autoimmunity reviews.

[167]  O. Vignaux,et al.  Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging , 2006, Annals of the rheumatic diseases.

[168]  G. Kitas,et al.  Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome , 2005, Annals of the rheumatic diseases.

[169]  I. Seimenis,et al.  Magnetic resonance angiography, function and viability evaluation in patients with Kawasaki disease. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[170]  A. Wunder,et al.  Molecular imaging: novel tools in visualizing rheumatoid arthritis. , 2005, Rheumatology.

[171]  Kay Nehrke,et al.  Rapid and complete coronary arterial tree visualization with magnetic resonance imaging: feasibility and diagnostic performance. , 2005, European heart journal.

[172]  H. Crijns,et al.  The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. , 2005, Chest.

[173]  P. Borne,et al.  MYOPERICARDITIS REVEALING ADULT-ONSET STILL’S DISEASE , 2005, Acta clinica Belgica.

[174]  R. Mohiaddin,et al.  Applications of phase-contrast flow and velocity imaging in cardiovascular MRI , 2005, European Radiology.

[175]  W. Dassen,et al.  Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. , 2005, Journal of the American College of Cardiology.

[176]  S. Gabriel,et al.  Cardiovascular death in rheumatoid arthritis: a population-based study. , 2005, Arthritis and rheumatism.

[177]  P. Woodard,et al.  Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report , 2005, Lupus.

[178]  S. Gabriel,et al.  The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. , 2005, Arthritis and rheumatism.

[179]  M. Petri,et al.  Cardiac Involvement in Systemic Lupus Erythematosus , 2003 .

[180]  C. Higgins,et al.  Imaging findings in Takayasu's arteritis. , 2005, AJR. American journal of roentgenology.

[181]  S. Neubauer,et al.  Subendocardial and papillary muscle involvement in a patient with Churg-Strauss syndrome, detected by contrast enhanced cardiovascular magnetic resonance , 2004, Heart.

[182]  E. Fleck,et al.  High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest. , 2004, Radiology.

[183]  J. Schulz-Menger,et al.  Delayed Enhancement and T2-Weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction , 2004, Circulation.

[184]  Jeroen J. Bax,et al.  Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. , 2004, European heart journal.

[185]  F. Granath,et al.  Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. , 2004, The Journal of rheumatology.

[186]  Udo Sechtem,et al.  Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.

[187]  I. Seimenis,et al.  Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. , 2004, Journal of the American College of Cardiology.

[188]  W. Ollier,et al.  Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. , 2004, Seminars in arthritis and rheumatism.

[189]  H. Crijns,et al.  Cardiac involvement of Churg Strauss syndrome demonstrated by magnetic resonance imaging. , 2004, Clinical and experimental rheumatology.

[190]  A. Al-nahhas,et al.  The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[191]  E. Onrat,et al.  Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis , 2003, Clinical Rheumatology.

[192]  F. Strutz,et al.  Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[193]  René M. Botnar,et al.  Coronary Magnetic Resonance Angiography , 2003, Herz.

[194]  K. Eagle,et al.  Choice of computed tomography, transesophageal echocardiography, magnetic resonance imaging, and aortography in acute aortic dissection: International Registry of Acute Aortic Dissection (IRAD). , 2002, The American journal of cardiology.

[195]  Y. Murakami,et al.  Myocarditis associated with polymyositis diagnosed by gadolinium-DTPA enhanced magnetic resonance imaging. , 2002, The Journal of rheumatology.

[196]  M. Abrahamowicz,et al.  Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. , 2001, Arthritis and rheumatism.

[197]  G. V. von Schulthess,et al.  Assessment of Myocardial Perfusion in Coronary Artery Disease by Magnetic Resonance: A Comparison With Positron Emission Tomography and Coronary Angiography , 2001, Circulation.

[198]  E Fleck,et al.  Comparison of magnetic resonance real-time imaging of left ventricular function with conventional magnetic resonance imaging and echocardiography. , 2001, The American journal of cardiology.

[199]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[200]  N. Hylton.  Suspension of breast-feeding following gadopentetate dimeglumine administration. , 2000, Radiology.

[201]  H. Oswald,et al.  Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. , 2000, Circulation.

[202]  E. Fleck,et al.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. , 1999, Circulation.

[203]  I. Yamada,et al.  Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. , 1998, Radiology.

[204]  R. Kim,et al.  Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. , 1996, Circulation.

[205]  Y. Shoenfeld,et al.  Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. , 1996, Circulation.

[206]  J. Bronzwaer,et al.  Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? , 1995, Circulation.

[207]  E. Topol,et al.  Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. , 1995, Circulation.

[208]  J. Im,et al.  Takayasu arteritis: evaluation of mural changes in the aorta and pulmonary artery with CT angiography. , 1995, Radiology.

[209]  J. Gottdiener,et al.  Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. , 1995, American journal of hypertension.

[210]  Nemchinov En,et al.  [Heart defects in rheumatoid arthritis patients (the results of a multiyear prospective clinico-echocardiographic study)]. , 1994 .

[211]  N. Chichasova,et al.  [Heart defects in rheumatoid arthritis patients (the results of a multiyear prospective clinico-echocardiographic study)]. , 1994, Terapevticheskii arkhiv.

[212]  R. Edelman,et al.  A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. , 1993, The New England journal of medicine.

[213]  H. Friedman.  Medical appropriateness of coronary angiograms. , 1991, The New England journal of medicine.

[214]  J. Best,et al.  Myocardial involvement in systemic lupus erythematosus detected by magnetic resonance imaging. , 1988, European Heart Journal.

[215]  C. Higgins,et al.  Atrial-level shunts: sensitivity and specificity of MR in diagnosis. , 1987, Radiology.

[216]  M. Srichai,et al.  Takayasu's Arteritis , 2012 .